Unique ID issued by UMIN | UMIN000021191 |
---|---|
Receipt number | R000024437 |
Scientific Title | Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer |
Date of disclosure of the study information | 2016/02/25 |
Last modified on | 2022/03/01 16:40:55 |
Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer
An ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer
Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer
An ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancer
Japan |
Colorectal cancer
Gastroenterology | Surgery in general | Gastrointestinal surgery |
Malignancy
YES
To determine the clinical significance of the detection of epigenetic heterogeneity in primary tumor and plasma from colorectal cancer patients with Methylation-sensitive high resolution melt(MS-HRM).
Efficacy
The detection rates of epigenetic heterogeneity in primary tumor and plasma from colorectal cancer patients with Methylation-sensitive high resolution melt(MS-HRM).
1.To investigate the diffenrences in the detection rates between quantitative methylation specific PCR (qMSP) and MS-HRM
2.To investigate the correlations between epigenetic heterogeneity and gene expression in primary tumor from colorectal cancer patients
Observational
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Patients are more than 20 and less than 80 years old
2.Patients without synchronous or metachronous multiple cancers
3.Eastern Cooperative Oncology Group performance status of 0, 1, or 2
4.Patients without severe complications (heart disease, liver disease, renal disease, infection)
5.All patients were required to give written informed consent prior to enrolment in the study
1.Patients do not meet the inclusion criteria
2.Patients without histologically confirmed cancer
3.Patients whom investigators consider to be ineligible
60
1st name | Kazuhiro |
Middle name | |
Last name | Sakamoto |
Juntendo University Faculty of Medicine
Department of Coloproctological Surgery
113-8421
3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
03-3813-3111
kazusaka@juntendo.ac.jp
1st name | Kiichi |
Middle name | |
Last name | Sugimoto |
Juntendo University Faculty of Medicine
Department of Coloproctological Surgery
113-8421
3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
03-3813-3111
ksugimo@juntendo.ac.jp
Juntendo University Faculty of Medicine
Our institution
Self funding
Juntendo University Faculty of Medicine
3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
03-3813-3111
ksugimo@juntendo.ac.jp
NO
2016 | Year | 02 | Month | 25 | Day |
Unpublished
No longer recruiting
2016 | Year | 02 | Month | 25 | Day |
2016 | Year | 02 | Month | 19 | Day |
2016 | Year | 03 | Month | 01 | Day |
2021 | Year | 12 | Month | 31 | Day |
Study design: Cohort study
Patient enrollment: Patients who undergo surgery for colorectal cancer in our department from February 2016 to December 2017
Examination: Laboratory test (WBC, RBC, Plt, AST, ALT, T-Bil, Cre) as well as methylated DNA measurement
2016 | Year | 02 | Month | 25 | Day |
2022 | Year | 03 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024437
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |